Pathophysiological roles of aldo–keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers

Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth

Tsutomu Ohta, Kumiko Iijima, Mamiko Miyamoto et al. · Cancer Research · 2008 · 628 citations

Medicine, Genetics, Oncology +15

Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer

Shinsuke Homma, Yukio Ishii, Yuko Morishima et al. · Clinical Cancer Research · 2009 · 417 citations

Medicine, Oncology, Pharmacology +14

Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells

C. Marzano, Valentina Gandin, Alessandra Folda et al. · Free Radical Biology and Medicine · 2006 · 415 citations

Life Sciences, Oncology, Pharmacology +15

Apoptosis by cisplatin requires p53 mediated p38α MAPK activation through ROS generation

Paloma Bragado, Alejandro Armesilla, Augusto Silva et al. · APOPTOSIS · 2007 · 370 citations

Life Sciences, Cell Biology, Oncology +14

Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1–NRF2 pathway, and not the BACH1–NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds

Annette MacLeod, Michael McMahon, Simon Plummer et al. · Carcinogenesis · 2009 · 293 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17